NVO261113C00031000
NVO Nov 13 2026 31.00 Call
optionOPRA
InactiveOct 8, 2026
6.85USD+7.874%(+0.50)2Vol1OI
Loading…
Underlying
Underlying Price
$38.90
Type
Call
Strike
31
Expiration
Nov 13, 2026
DTE
20d
Moneyness
ITM
Intrinsic
$7.90
NVO 31 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | $8.79 | +4.27% | 7 | 27 |
| Oct 30, 2026 | 6d | — | — | 0 | 0 |
| Nov 6, 2026 | 13d | $8.15 | -4.79% | 5 | 12 |
| Nov 13, 2026 | 20d | $6.85 | +7.87% | 2 | 1 |
| Nov 27, 2026 | 34d | — | — | 0 | 0 |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.